Browsing Tag
Rinatabart Sesutecan
1 post
Genmab targets new oncology growth as Rina-S delivers major survival gains over chemotherapy
Genmab stock jumps 9.5% after Rina-S delivers major ovarian cancer survival gains. Explore its FDA prospects, competition and growth outlook.